|Manufacturer:||Taro Pharmaceuticals Inc.|
by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1Issued: April, 2007PK-4964-1 1040
FLUOCINONIDE CREAM USP, 0.05%, FLUOCINONIDE CREAM USP, 0.05% (Emulsified Base), FLUOCINONIDE GEL USP, 0.05% and FLUOCINONIDE OINTMENT USP, 0.05% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
-- impairment of health or a condition of abnormal functioning of the skin.
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
-- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor.
It should not to be used for self-diagnosis or treatment.